Consider current large-scale practices for oligonucleotide synthesis as a basis for improving commercial-scale platform strategies.
Tony Pavone
Advertisement
Tony Pavone is retired professor of Chemical Engineering, Stanford University.
Articles by Tony Pavone
Advertisement
Latest Updated Articles
Designing Commercial-Scale Oligonucleotide SynthesisPublished: February 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
4
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
5
